(Q48030230)

7 February 2018

title

Clinical outcome in stage I to III breast carcinoma and eIF4E overexpression. (English)

1 reference

7 February 2018

1 reference

1 reference

B D Li

1

1 reference

7 February 2018

J C McDonald

series ordinal

2

1 reference

7 February 2018

R Nassar

series ordinal

3

1 reference

7 February 2018

A De Benedetti

series ordinal

4

1 reference

7 February 2018

language of work or name

English

0 references

publication date

1 May 1998

1 reference

7 February 2018

published in

Annals of Surgery

1 reference

7 February 2018

volume

227

1 reference

7 February 2018

page(s)

756-6l; discussion 761-3

1 reference

7 February 2018

issue

5

1 reference

7 February 2018

Why data bases should not replace randomized clinical trials

cites work

1 reference

12 December 2020

Elevated expression of eIF4E and FGF-2 isoforms during vascularization of breast carcinomas

1 reference

12 December 2020

Regulated phosphorylation and low abundance of HeLa cell initiation factor eIF-4F suggest a role in translational control. Heat shock effects on eIF-4F

1 reference

12 December 2020

Overexpression of eukaryotic protein synthesis initiation factor 4E in HeLa cells results in aberrant growth and morphology

1 reference

12 December 2020

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

1 reference

12 December 2020

Expression of antisense RNA against initiation factor eIF-4E mRNA in HeLa cells results in lengthened cell division times, diminished translation rates, and reduced levels of both eIF-4E and the p220 component of eIF-4F.

1 reference

12 December 2020

mRNAs containing extensive secondary structure in their 5' non-coding region translate efficiently in cells overexpressing initiation factor eIF-4E

1 reference

12 December 2020

Mechanism of action and regulation of protein synthesis initiation factor 4E: effects on mRNA discrimination, cellular growth rate, and oncogenesis.

1 reference

12 December 2020

Decreasing the level of translation initiation factor 4E with antisense RNA causes reversal of ras-mediated transformation and tumorigenesis of cloned rat embryo fibroblasts.

1 reference

12 December 2020

Elevated levels of cyclin D1 protein in response to increased expression of eukaryotic initiation factor 4E

1 reference

12 December 2020

Overproduction of ornithine decarboxylase caused by relief of translational repression is associated with neoplastic transformation.

1 reference

12 December 2020

The proto-oncogene/translation factor eIF4E: A survey of its expression in breast carcinomas

1 reference

12 December 2020

Translational enhancement of FGF-2 by eIF-4 factors, and alternate utilization of CUG and AUG codons for translation initiation.

1 reference

12 December 2020

Translational regulation of vascular permeability factor by eukaryotic initiation factor 4E: implications for tumor angiogenesis

1 reference

12 December 2020

Overexpression of the proto-oncogene/translation factor 4E in breast-carcinoma cell lines

1 reference

12 December 2020

Overexpression of eukaryotic initiation factor 4E (eIF4E) in breast carcinoma

1 reference

12 December 2020

Detection of the proto-oncogene eIF4E in surgical margins may predict recurrence in head and neck cancer

1 reference

12 December 2020

The role of observational studies in the evaluation of therapy

1 reference

12 December 2020

10.1097/00000658-199805000-00016

Identifiers

DOI

1 reference

7 February 2018

0 references

1 reference

7 February 2018